| |
| Vol. 1, No. 3 & 4 |
May and June 2002 |
|
Jerry Bylander, Editor jerryby@texoma.net |
| The Managing Director's Column |
USToo Texoma did not meet in May; we were unable to line up
a speaker. Many of our speakers are of the opinion that there is ample
information out there and especially on the web. As a result they are
unwilling to go over the same material. Your board is addressing this
issue in three ways: put up information on our web site:
<www.ustoo-texoma.org>, recognize there are new patients all the
time and a live teacher (doctor) is more effective than reading material,
and by having Sherman meetings every other month. This May, for example,
TMC and The American Cancer Society had a prostate cancer (CaP) support
group meeting in Denison instead of USToo Texoma. It was very successful
as witnessed by the attendance at theTMC event. There were some 35
attendees and many were first timers from areas of Texoma we don't usually
reach. This result suggests alternating meetings between Sherman (the
USToo group) and Denison (the Man to Man group). The result will be that a
larger group of CaP sufferers is reached by a larger pool of speakers. It
also effectively blunts any charges of lack of cooperation between various
interest groups-I fondly hope. Remember you are and important part of our support group. USTOO Texoma needs you! See you at our next meeting. Dr. Jerry Bylander, Managing Director, USToo! Texoma By the way, if you haven't been to our web page lately, check it out at www.ustoo-texoma.org . |
| Next Meeting |
Tuesday Evening, September
2002
Wilson N.
Jones North -Senior Health
Center
3305 Calais
Street, South Entrance
Sherman, TX
6:30 PM - Social &
Coffee
7:00 PM -
Program
| Program: TBA |
| Speaker: TBA |
| Last Meeting |
| Date & Time: | Tuesday, March 19, 2002, 7:00 PM |
| Place: | Wilson N. Jones, North Senior Health Center |
| Attendance: | Est. 20 attendees |
| Old Business
None. New Business Henri Puckett, the Program Chair, announced the May program to be sponsored by TMC. Program: Hormonal therapy; a treatment for prostate cancer Speaker: R.B. McGowan Program: R.B., who has done extensive research on hormone therapy , described the learn options he has explored for treatment. The meeting adjourned about 9 PM. Henry Puckett, Program Chair/by the Editor |
| Other Important Events |
| Your organization's meetings listed here. Contact the Editor at jerryby@texoma.net |
| Editor's Notes |
Random thoughts from your editor New Genetic Marker for
CaP Scientific American Copied from Fierce Wireless "Researchers at the University of Michigan have a gene that's overexpressed in prostate cancer tissue that could help point a way to better a prostate cancer screening test." PC Spes, a last-resort drug is discontinued from the Wall Street Journal, Tuesday, May 21, 2001, p. D4 and Prostate Cancer Hot Sheet, March, 2002, p. 1 The California Department of Health thinks they have found warfarin in PC SPES. The substance thought to be warfarin, which is available by prescription alone, may be instead phytocoumarin which is naturally synthesized in green plants. As a result the manufacturer has recalled the product. The WSJ reports the manufacturer is going out of business "leaving most of the 10,000 men with little alternative except chemotherapy to keep them alive." As many of you may recall, two of our recent speakers tell us that chemotherapy only serves to reduce pain and doesn't affect the outcome of CaP. In fact they tell us that with this end stage cancer, life expectancy is only 6 months to a year and a half. The WSJ reports that 7500 of the men taking PC SPES have this end stage cancer, and are hormone refractory (Lupron and Casodex don't work) and PC SPES has held down PSA for many years"...with minimal side effects" of reduced libido, etc. The shame of this is that the men benefiting who will live less than 1.5 years without the PC SPES can't possibly be harmed any further than this painful cancer is by a blood thinner (you probably know that aspirin and ibuprofen are blood thinners which are over-the-counter drugs). In your editors opinion, this result is just one more example of our dysfunctional medical and pharmacological system. Seeds
Explained The methods include combining external beam and hormone treatments with the seeds. Also a drilled template, based on a 3-D rendering of the gland, may be used. Radio iodine or palladium have been used as seeds. They are coated with titanium and are about as wide as a straight pin. Sixty to 130 seeds are used. They decay to low levels within a year. Usually seeds are used without external beam for Gleason scores below 6 (T1c or T2a). If the patient is deemed to be at high risk androgen (hormone) therapy will be continued for up to 6 months after the treatment. Also Gleason scores above 7 and PSA above 15 will require a boost implant followed by 5 weeks of radiation therapy. Potency will remain for more than 50% of patients depending on age; Viagra may also help. Apparently treatments for recurrence after seeds is largely by trial and error at this point. Book Review:
"His Prostate and Me" "His Prostate and Me" addresses from a woman's point of view the prime issue that obstructs men from seeking treatment for prostate cancer: will I or won't I be able to function sexually for the rest of my life? Desiree Howe met and married husband Dick Howe after his prostate cancer surgery, answers that question with a resounding yes as she offers a frank and information-rich examination of her husband's and her experience with this "dangerous" disease. The keystone of the gook is Dick Howe's story, from diagnosis all the way through successful treatment for post-surgical side effects, including erectile dysfunction...Patients, survivor groups and physicians alike will benefit from reading the Howe's story....Every wife, partner or loved one of a man diagnosed with prostate cancer will derive tremendous insight and guidance from the Howes' story. Windalye Publishing, paperback (April 2002), $16.00. Amazon: $16.80 + S&H. Mayo Clinic has a service to help early stage men decide on a best treatment MAScribe Newswire - April 13,
2002 WFree PSA may double PSA Accuracy The Prostate Cancer Hot Sheet for May 2002 reports results of two new studies which found that free/total PSA ratios almost double the detection of prostate cancer. From the Scripps Howard News Service - 9/19 and The May 2002
Hot Sheet
|